Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") announces today its fourth quarter and full year 2025 financial results.
Property operations have become harder to manage quietly in the background. Costs are tracked more closely. Investors expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results